Australia markets closed

Cross Country Healthcare, Inc. (CCRN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
14.93-1.48 (-9.02%)
At close: 04:00PM EDT
15.20 +0.27 (+1.81%)
After hours: 06:38PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 519.18M
Enterprise value 518.43M
Trailing P/E 11.31
Forward P/E 21.32
PEG ratio (5-yr expected) 2.13
Price/sales (ttm)0.29
Price/book (mrq)1.11
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.77
52-week change 3-39.82%
S&P500 52-week change 326.27%
52-week high 328.75
52-week low 314.81
50-day moving average 317.70
200-day moving average 321.13

Share statistics

Avg vol (3-month) 3423.68k
Avg vol (10-day) 3472.03k
Shares outstanding 534.77M
Implied shares outstanding 634.77M
Float 832.68M
% held by insiders 15.16%
% held by institutions 1104.41%
Shares short (30 Apr 2024) 44.72M
Short ratio (30 Apr 2024) 419.76
Short % of float (30 Apr 2024) 417.45%
Short % of shares outstanding (30 Apr 2024) 413.58%
Shares short (prior month 28 Mar 2024) 45.13M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 2.58%
Operating margin (ttm)2.14%

Management effectiveness

Return on assets (ttm)6.36%
Return on equity (ttm)9.97%

Income statement

Revenue (ttm)1.78B
Revenue per share (ttm)51.12
Quarterly revenue growth (yoy)-39.10%
Gross profit (ttm)N/A
EBITDA 97.46M
Net income avi to common (ttm)45.89M
Diluted EPS (ttm)1.32
Quarterly earnings growth (yoy)-90.90%

Balance sheet

Total cash (mrq)5.24M
Total cash per share (mrq)0.15
Total debt (mrq)4.49M
Total debt/equity (mrq)0.96%
Current ratio (mrq)3.02
Book value per share (mrq)13.64

Cash flow statement

Operating cash flow (ttm)207.64M
Levered free cash flow (ttm)189.46M